BullFrog AI Holdings (BFRGW) Interest & Investment Income (2023 - 2026)
BullFrog AI Holdings' (BFRGW) quarterly Interest & Investment Income came in at $49904.0 in Q2 2026, up 113.33% on a YoY basis from $23393.0 in Q2 2025, and up 113.33% quarter-over-quarter from $23393.0 in Q2 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Interest & Investment Income (2023 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Interest & Investment Income for 4 consecutive years, with $49904.0 the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.63 Bn | 197.64 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.39 Bn | 178.21 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.32 Bn | 124.47 Bn | 2.84 Bn | 120.60 Mn |
| 4 | Regeneron Pharmaceuticals | 82.47 Bn | 74.47 Bn | 3.93 Bn | -48.00 Mn |
| 5 | Argenx Se | 61.52 Bn | 56.34 Bn | 1.37 Bn | 48.00 Mn |
| 6 | Moderna | 54.79 Bn | 49.65 Bn | 52.00 Mn | 67.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.04 Bn | 30.73 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Biogen | 31.39 Bn | 30.11 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | 36.92 Mn |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | 49,904.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49,904.00 |
| Jun 30, 2025 | 23,393.00 |
| Mar 31, 2024 | 65,197.00 |
| Mar 31, 2023 | 18,338.00 |